ABSTRACT Introduction: toxoplasmosis is a parasitosis that causes serious infections in immunocompromised patients and newborns. The serological status of the mother influences the possibility of transmission to the fetus if the infection is contracted during pregnancy. It is necessary to know the prevalence of this condition in pregnant women as a first step to carry out actions aimed at knowing the real burden of the disease and reducing this pathology. Objective: determine the IgG and IgM seroprevalence of toxoplasmosis in pregnant women and newborns from January 2017 to January 2021. Methodology: pregnant women in their immediate peripartum period and newborns up to one week of extrauterine life were included. IgG and IgM were measured in peripheral blood by the ECLIA method. The calculated sample size was 800 per group, for the study period. Results: 2524 newborns and 2029 pregnant women were included. The prevalence of IgG was 97.5 % and 97 % for pregnant women and newborns, respectively, and IgM: 4.7 % and 1.9% for women and newborns, respectively. The seroprevalence trends remained constant for IgG for both groups, while IgM showed a slight increasing trend. Conclusions: IgG seroprevalence was close to 100% in both populations, probably due to the transplacental transfer of IgG, however, a small percentage of IgM was noted, a probable marker of acute infection.

RESUMEN Introducción: la toxoplasmosis es una parasitosis que causa infecciones graves en inmunocomprometidos y recién nacidos. El estado serológico de la madre influye en la posibilidad de transmisión al feto si la infección es contraída durante el embarazo. Es necesario conocer la prevalencia de esta afección en gestantes como primer paso para realizar acciones tendientes a conocer la carga real de la enfermedad y disminuir esta patología. Objetivo: determinar la seroprevalencia IgG e IgM de toxoplasmosis de gestantes y recién nacidos periodo de enero 2017 a enero 2021. Metodología: se incluyeron las gestantes en su periodo periparto inmediato y recién nacidos hasta la semana de vida extrauterina. Se midió IgG e IgM en sangre periférica por método ECLIA. El tamaño muestral calculado fue de 800 por grupo, para el periodo de estudio. Muestreo no probabilístico de casos consecutivos. Resultados: fueron incluidos 2524 recién nacidos y 2029 gestantes. Las prevalencias de IgG fueron de 97,5 % y 97 % para gestantes y recién nacidos respectivamente, y la IgM: 4,7% y 1,9 % para mujeres y recién nacidos respectivamente. Las tendencias de las seroprevalencias se mantuvieron constantes para IgG para ambos grupos, mientras que la IgM presentó una leve tendencia al aumento. Conclusiones: la seroprevalencia de IgG fue cercana al 100 % en ambas poblaciones, probablemente debido a la transferencia transplacentaria de IgG, sin embargo, se nota un porcentaje pequeño de IgM, probable marcador de infección aguda.

ABSTRACT Introduction. Due to the cross-reactivity between SARS-CoV-2 and common human coronaviruses, previous infections with these viruses could contribute to serological or cellular cross-protection against severe COVID-19. However, protective immunity may not develop, or pre-existing immunity could increase COVID-19 severity. Objective. To determine the seroprevalence of IgG antibodies against HCoV-NL63 and HCoV-HKU1 and correlate previous exposure with COVID-19 signs in patients from Villavicencio. Materials and methods. A cross-sectional retrospective study was conducted. ELISA technique was used to search for IgG antibodies against HCoV-NL3 and HCoV-HKU1 in patients with positive RT-qPCR results for SARS-CoV-2. Patients were grouped according to COVID-19 clinical characteristics in four groups: group 1: asymptomatic (n = 23); group 2: hospitalized (n = 24); group 3: intensive care units (n = 24), and group 4: dead (n = 22). Results. The overall seroprevalence of IgG antibodies against HCoV was 74.2% (n = 69; 95% CI: 65.3-83.1), with 66.7% of HCoV-NL63 (n = 62; 95% CI: 57,1-76,2), and 25.8% of HCoV-HKU1 (n = 24; 95% CI: 16,9-34,7). Based on crosstab analysis, prior exposure to HCoV-NL63 was associated with protection against severe COVID-19 (p = 0.042; adjusted OR = 0.159; 95% CI: 0.027-0.938), and previous coinfection of HCoV-NL63 and HCoV-HKU1 was considered a positive association to severe COVID-19 (p = 0.048; adjusted OR = 16.704; 95% CI: 1.020 - 273.670). Conclusion. To our knowledge, this is the first study addressing seroprevalence of HCoV IgG antibodies in Colombia and Latin America. Previous exposure to HCoV-NL63 could protect against severe COVID-19, whereas patients with underlying HCoV-NL63 and HCoV-HKU1 coinfection could be hospitalized with severe signs of COVID-19.

RESUMEN Introducción. Debido a la reactividad cruzada entre SARS-CoV-2 y los coronavirus humanos comunes, las infecciones previas con estos virus podrían contribuir a la protección cruzada serológica o celular contra la COVID-19 grave. Sin embargo, la inmunidad protectora puede no desarrollarse o la inmunidad preexistente podría generar COVID-19 grave. Objetivo. Determinar la seroprevalencia de anticuerpos IgG frente a HCoV-NL63 y HCoV-HKU1, y correlacionar su previa exposición con los signos de COVID-19 en pacientes de Villavicencio. Materiales y métodos. Se realizó un estudio retrospectivo observacional analítico y transversal. Se utilizó la técnica ELISA para buscar anticuerpos IgG contra HCoV-NL3 y HCoV-HKU1 en pacientes con resultado positivo de RT-qPCR para SARS-CoV-2. Los pacientes se agruparon según los signos de COVID-19 en cuatro grupos: grupo 1: asintomáticos (n = 23); grupo 2: hospitalizados (n = 24); grupo 3: unidad de cuidados intensivos (n = 24), y grupo 4: fallecidos (n = 22). Resultados. La seroprevalencia general de IgG anti-HCoV fue de 74.2 % (n = 69; IC95%: 65,3-83,1), con 66,7 % de HCoV-NL63 (n = 62; IC95%: 57,1-76,2) y 25,8 % de HCoV-HKU1 (n = 24; [IC95%:16,9-34,7). Según el análisis de las tablas de contingencia, la exposición previa a HCoV-NL63 se asoció con protección de una COVID-19 grave (p = 0,042; OR ajustado = 0,159; IC95%: 0,027-0,938) y la previa coinfección de HCoV-NL63 y HCoV-HKU1 se asoció con padecimiento de signos clínicos graves por COVID-19 (p = 0,048; OR ajustado = 16,704; IC95%: 1,020- 73,670). Conclusión. Según la literatura revisada hasta la fecha, este es el primer estudio sobre la seroprevalencia de anticuerpos IgG de HCoV en Colombia y Latinoamérica. La exposición previa a HCoV-NL63 podría proteger contra la COVID-19 grave, mientras que los pacientes con coinfección subyacente de HCoV-NL63 y HCoV-HKU1 podrían resultar hospitalizados con signos graves de COVID-19.

Abstract Porcine circovirus type 2 (PCV2) is a DNA-type virus that has an affinity for cells of the immune system and generates lymphocyte depletion so it favors the development of diseases caused by other opportunistic agents, it is also related to the generation of different syndromes. Therefore, this virus causes major illnesses on the pig industry; nevertheless, PCV2-associated syndromes can easily be prevented through the proper application of biosecurity and vaccination measures. On the other hand, small-scale production units (SPUs) often lack this type of preventive management, as well as routine surveillance by a veterinarian. Although PCV2 is considered a widely distributed virus, there are no reports of its presence in SPUs in Nuevo León. The presence of antibodies against PCV2 was determined using a commercial kit and complete blood count was performed on the animals. A total of 48 SPUs were found, with 91.67 % positivity and 89.7 % seropositivity in the animals. In the complete blood count, it was found that HGB and HCT were decreased in individuals who were positive for antibodies compared to negative ones (P=0.03 and P=0.01, respectively); on the contrary, the value of total white blood cells was found to be decreased in individuals who were negative for the presence of antibodies against PCV2 (P=0.01).

Resumen El circovirus porcino tipo 2 (PCV2) es un virus de tipo DNA que tiene afinidad por células del sistema inmune y que genera depleción de linfocitos por lo que favorece el desarrollo de enfermedades causadas por otros agentes oportunistas, así mismo está relacionado con la generación de diferentes síndromes. Por lo anterior, este virus produce importantes afecciones a la industria porcícola, sin embargo, fácilmente se pueden prevenir los síndromes asociados a PCV2 mediante la adecuada aplicación de medidas de bioseguridad y vacunación. Por otro lado, las unidades de producción a pequeña escala (UPPs) suelen carecer de este tipo de manejo preventivo, así como de vigilancia rutinaria por parte de un médico veterinario. Si bien, el PCV2 se considera un virus ampliamente distribuido, no existen reportes de su presencia en las UPPs en Nuevo León. Se determinó la presencia de anticuerpos contra PCV2 mediante el uso de un kit comercial y se realizó la biometría hemática de los animales. Se localizaron 48 UPPs en las que se encontró un 91.67% de positividad, así como un 89.7% de seropositividad en los animales. En la biometría se encontró que la HGB y el HCT se presentaron disminuidos en los individuos que resultaron positivos a anticuerpos comparados contra los negativos (P=0.03 y P=0.01, respectivamente), por el contrario, el valor de células blancas totales se encontró disminuido en los individuos que resultaron negativos a la presencia de anticuerpo contra PCV2 (P=0.01).

Abstract: Worldwide, there is an alert due to the increase in the seroprevalence of hepatitis B virus (HBV). This can cause up to 3.5% of chronic diseases, of which 40% present secondary complications and/ or early death. Objective: To determine the seroprevalence of HBV in pregnant women at the time of delivery. Patients and Method: Observational, descriptive, cross-sectional study with cross-association between 2018 and 2019 at the Hospital Carlos Van Buren (HCVB), in Valparaiso, Chile. All pregnant women admitted for delivery care or with an immediate newborn who had HBV surface antigen study were included. Data were collected from the pregnant woman (age, nationality, education level, parity, type of delivery, and peripartum HIV-syphilis serology) and the newborn (gestational age, weight, and APGAR score). Inferential and multivariate analysis was performed using the Stata software. Results: 1,355 pregnant women were analyzed. 87.7% were Chilean, 5.5% Haitian, 4.2% Venezuelan, and 2.6% were of other nationalities. 0.3% were positive for HBV. The prevalence of HBV in Chileans was 0.08% and in Haitians 4%. Haitian nationality was at higher risk of HBV (OR = 83) vs. Chilean nationality (p = 0.0001). None presented coinfection with HIV and/or syphilis. Conclusions: HBV seroprevalence in HCVB pregnant women was 0.3%, similar to that described in the general population in Chile. There was no coinfection with other sexually transmitted diseases. The only predictor of HBV infection was Haitian nationality.

Resumen: Existe una alerta a nivel mundial por el aumento de la seroprevalencia del virus hepatitis B (VHB), el que puede ocasionar hasta un 3,5% de enfermedad crónica, de los cuales un 40% presenta complicaciones secundarias y/o muerte anticipada. Objetivo: Determinar la seroprevalencia de VHB de gestantes al momento del parto. Pacientes y Método: Estudio observacional descriptivo de corte transversal con asociación cruzada entre los años 2018 y 2019, en el Hospital Carlos Van Buren (HCVB), Valparaíso, Chile. Se incluyeron todas las gestantes que ingresaron para la atención del parto o con recién nacido inmediato que tenían el resultado del antígeno de superficie de VHB. Se recopilaron datos de la gestante (edad, nacionalidad, escolaridad, paridad, tipo de parto y serología VIH-sífilis periparto) y del recién nacido (edad gestacional, peso y APGAR). Se aplico análisis inferencial y multivariado con Stata. Resultados: Se analizaron 1.355 gestantes. Un 87,7% de nacionalidad chilena, 5,5% haitianas, 4,2% venezolanas y 2,6% de otras nacionalidades. El 0,3% resultaron positivas para VHB. La prevalencia de VHB en chilenas fue 0,08% y en haitianas 4%. La nacionalidad haitiana resultó de mayor riesgo de VHB (OR = 83) versus la nacionalidad chilena (p = 0,0001). Ninguna presentó coinfección con VIH y/o Sífilis. Conclusiones: La seroprevalencia de VHB en gestantes del HCVB fue de 0.3%, similar a la población general en Chile. No existió coinfección con otras enfermedades de transmisión sexual. El único factor predictor de infección por VHB fue la nacionalidad haitiana.

BACKGROUND: COVID-19 has been a major public health concern globally, leading to a higher mortality rate, especially among immunosuppressed individuals, who include pregnant women, people with HIV and people living with other comorbidities. Pregnant women are considered to be a special population group owing to their specific susceptibility to some infectious diseases. OBJECTIVE: To determine the seroprevalence of anti-SARS-CoV-2 antibodies among pregnant women attending an antenatal clinic. METHOD: This was a descriptive cross-sectional study that tested blood samples from pregnant women who attended the antenatal clinic from March to July 2022 using the Orient Gene Biotech lateral flow immune-chromatographic assay according to manufacturer instructions. The assay detects IgM and IgG antibodies against SARS-CoV-2. RESULTS: A total of 2 649 blood samples were tested; 2 039 (77.0%) samples tested positive for IgG, 7 (0.3%) tested positive for IgM, and 100 (3.7%) tested positive for both IgG and IgM. The study found a seroprevalence of 80.7% of IgG. CONCLUSION: The study findings showed evidence of acute COVID-19 infection in our patient population despite the consensus that COVID-19 infection is dissipating.

Abstract Introduction. In 2021, the Secretaría de Salud de México and the Pan American Health Organization launched an initiative to interrupt intra-domiciliary vector transmission of Trypanosoma cruzi based on the prevalence of Chagas disease in children. The Mexican State of Veracruz was leading this initiative. Objective. To estimate the seroprevalence of T. cruzi infection among children under 15 years of age from rural areas of Veracruz, México. Materials and methods. We identified eight localities of high priority from the Municipality of Tempoal, Veracruz, for baseline serology. Blood samples were collected on filter paper from 817 individuals between June and August 2017, for screening with a third-generation enzyme immunoassay. Reactive cases were confirmed by indirect hemagglutination, enzyme-linked immunosorbent assay, and indirect immunofluorescence tests on peripheral blood serum samples. We calculated seroprevalence and 95% confidence intervals (CI). Results. We confirmed Chagas disease cases in children under 15 years of age with a seroprevalence of 1,9% (95 % CI = 1,12-3,16) in the localities of Citlaltepetl, Cornizuelo, Cruz de Palma and Rancho Nuevo. Conclusions. These results indicate recent transmission of T. cruzi in these communities and allow to establish an epidemiological baseline for the design and implementation of a model focused on geographical areas with active transmission to advance toward the elimination of intra-domiciliary vector transmission of this parasite in Mexico.

Resumen Introducción. En el 2021, la Secretaría de Salud de México y la Organización Panamericana de la Salud lanzaron una iniciativa para interrumpir la transmisión vectorial intradomiciliaria de Trypanosoma cruzi, fundamentada en la prevalencia de la enfermedad de Chagas en la población infantil. El estado mexicano de Veracruz fue el pionero de esta iniciativa. Objetivo. Estimar la seroprevalencia de infección por T. cruzi en menores de 15 años de localidades rurales de Veracruz, México. Materiales y métodos. Se identificaron ocho localidades prioritarias para la serología basal del municipio de Tempoal, Veracruz. Entre junio y agosto de 2017, se recolectaron muestras de sangre en papel filtro de 817 individuos para su tamizaje mediante un inmunoensayo enzimático de tercera generación. Los casos reactivos del tamizaje se confirmaron mediante pruebas de hemaglutinación indirecta, ensayo de inmunoabsorción ligado a enzimas e inmunofluorescencia indirecta en muestras de suero. Se calculó la seroprevalencia y su intervalo de confianza (IC) del 95 %. Resultados. En las localidades de Citlaltépetl, Cornizuelo, Cruz de Palma y Rancho Nuevo se confirmaron casos de la enfermedad de Chagas en menores de 15 años con una seroprevalencia de 1,9 % (IC 95 % = 1,12-3,16). Conclusiones. Los resultados indican que estas comunidades presentan transmisión reciente de T. cruzi y permiten establecer una línea epidemiológica de base para el diseño e implementación de un modelo dirigido a aquellas áreas geográficas con transmisión activa. Se espera que dicho modelo contribuya a la eliminación de la transmisión vectorial intradomiciliaria del tripanosomátido en México.

BACKGROUND: Patterns of SARS-CoV-2 spread have varied by geolocation, with differences in seroprevalence between urban and rural areas, and between waves. Household spread of SARS-CoV-2 is a known source of new COVID-19 infections, with rural areas in sub-Saharan Africa being more prone than urban areas to COVID-19 transmission because of limited access to water in some areas, delayed health-seeking behaviour and poor access to care OBJECTIVES: To explore SARS-CoV-2 infection incidence and transmission in rural households in South Africa (SA METHODS: We conducted a prospective household cluster investigation between 13 April and 21 July 2021 in the Matjhabeng subdistrict, a rural area in Free State Province, SA. Adults with SARS-CoV-2 confirmed by polymerase chain reaction (PCR) tests (index cases, ICs) and their household contacts (HCs) were enrolled. Household visits conducted at enrolment and on days 7, 14 and 28 included interviewer-administered questionnaires and respiratory and blood sample collection for SARS-CoV-2 PCR and SARS-CoV-2 immunoglobulin G serological testing, respectively. Co-primary cases were HCs with a positive SARS-CoV-2 PCR test at enrolment. The incidence rate (IR), using the Poisson distribution, was HCs with a new positive PCR and/or serological test per 1 000 person-days. Associations between outcomes and HC characteristics were adjusted for intra-cluster correlation using robust standard errors. The secondary infection rate (SIR) was the proportion of new COVID-19 infections among susceptible HCs RESULTS: Among 23 ICs and 83 HCs enrolled, 10 SARS-CoV-2 incident cases were identified, giving an IR of 5.8 per 1 000 person-days (95% confidence interval (CI) 3.14 - 11.95). Households with a co-primary case had higher IRs than households without a co-primary case (crude IR 14.16 v. 1.75, respectively; p=0.054). HIV infection, obesity and the presence of chronic conditions did not materially alter the crude IR. The SIR was 15.9% (95% CI 7.90 - 29.32). Households with a lower household density (fewer household members per bedroom) had a higher IR (IR 9.58; 95% CI 4.67 - 21.71) than households with a higher density (IR 3.06; 95% CI 1.00 - 12.35 CONCLUSION: We found a high SARS-CoV-2 infection rate among HCs in a rural setting, with 48% of households having a co-primary case at the time of enrolment. Households with co-primary cases were associated with a higher seroprevalence and incidence of SARS-CoV-2. Sociodemographic and health characteristics were not associated with SARS-CoV-2 transmission in this study, and we did not identify any transmission risks inherent to a rural setting

Abstract 17. This study investigates the prevalence of Coxiella burnetii antibodies in sheep and examines the seasonal impact on Q fever distribution. A total of 253 blood samples from sheep in Bosnia and Herzegovina during summer and winter were used, and, the research employed ELISA testing for antibody detection. Findings revealed a significant seasonal variation in seroprevalence, with 41 positive cases identified: 37 in winter and 4 in summer, indicating a higher infection rate during colder months. Statistical analysis suggests a significant association (p<0.05) between season and infection rates; winter conditions, increased indoor density, and lambing activities may elevate transmission risks. These results underscore the importance of considering seasonal factors in Q fever management and surveillance in sheep, contributing to a better understanding of its epidemiology and informing public health strategies. The study highlights the need for further systemic-epidemiological research across different geographies and management practices to elucidate the full impact of seasonality on Q fever prevalence.

Resumen 21. El estudio evaluó la prevalencia de Coxiella burnetii en ovejas en Bosnia y Herzegovina durante las estaciones de verano e invierno y determino el impacto estacional en la distribución de la fiebre Q. Se utilizaron 253 muestras de sangre de ovejas para determinar la presencia de anticuerpos contra C. burnetii mediante de la prueba ELISA. Los hallazgos revelaron una variación estacional significativa en la seroprevalencia, con 41 casos positivos identificados: 37 en invierno y 4 en verano, lo que indica una mayor tasa de infección durante los meses más fríos. El análisis estadístico sugiere una asociación significativa entre la temporada y las tasas de infección (p<0,05). Las condiciones invernales, el aumento de la densidad interior y las actividades de parto pueden elevar los riesgos de transmisión. Los resultados subrayan la importancia de considerar los factores estacionales en el manejo y vigilancia de la fiebre Q en ovejas, contribuyendo a una mejor comprensión de su epidemiología e informando las estrategias de salud pública. El estudio destaca la necesidad de realizar más investigaciones epidemiológicas sistémicas en diferentes geografías y prácticas de gestión para dilucidar el impacto total de la estacionalidad en la prevalencia de la fiebre Q.

Abstract: Worldwide, there is an alert due to the increase in the seroprevalence of hepatitis B virus (HBV). This can cause up to 3.5% of chronic diseases, of which 40% present secondary complications and/ or early death. Objective: To determine the seroprevalence of HBV in pregnant women at the time of delivery. Patients and Method: Observational, descriptive, cross-sectional study with cross-association between 2018 and 2019 at the Hospital Carlos Van Buren (HCVB), in Valparaiso, Chile. All pregnant women admitted for delivery care or with an immediate newborn who had HBV surface antigen study were included. Data were collected from the pregnant woman (age, nationality, education level, parity, type of delivery, and peripartum HIV-syphilis serology) and the newborn (gestational age, weight, and APGAR score). Inferential and multivariate analysis was performed using the Stata software. Results: 1,355 pregnant women were analyzed. 87.7% were Chilean, 5.5% Haitian, 4.2% Venezuelan, and 2.6% were of other nationalities. 0.3% were positive for HBV. The prevalence of HBV in Chileans was 0.08% and in Haitians 4%. Haitian nationality was at higher risk of HBV (OR = 83) vs. Chilean nationality (p = 0.0001). None presented coinfection with HIV and/or syphilis. Conclusions: HBV seroprevalence in HCVB pregnant women was 0.3%, similar to that described in the general population in Chile. There was no coinfection with other sexually transmitted diseases. The only predictor of HBV infection was Haitian nationality.

Resumen: Existe una alerta a nivel mundial por el aumento de la seroprevalencia del virus hepatitis B (VHB), el que puede ocasionar hasta un 3,5% de enfermedad crónica, de los cuales un 40% presenta complicaciones secundarias y/o muerte anticipada. Objetivo: Determinar la seroprevalencia de VHB de gestantes al momento del parto. Pacientes y Método: Estudio observacional descriptivo de corte transversal con asociación cruzada entre los años 2018 y 2019, en el Hospital Carlos Van Buren (HCVB), Valparaíso, Chile. Se incluyeron todas las gestantes que ingresaron para la atención del parto o con recién nacido inmediato que tenían el resultado del antígeno de superficie de VHB. Se recopilaron datos de la gestante (edad, nacionalidad, escolaridad, paridad, tipo de parto y serología VIH-sífilis periparto) y del recién nacido (edad gestacional, peso y APGAR). Se aplico análisis inferencial y multivariado con Stata. Resultados: Se analizaron 1.355 gestantes. Un 87,7% de nacionalidad chilena, 5,5% haitianas, 4,2% venezolanas y 2,6% de otras nacionalidades. El 0,3% resultaron positivas para VHB. La prevalencia de VHB en chilenas fue 0,08% y en haitianas 4%. La nacionalidad haitiana resultó de mayor riesgo de VHB (OR = 83) versus la nacionalidad chilena (p = 0,0001). Ninguna presentó coinfección con VIH y/o Sífilis. Conclusiones: La seroprevalencia de VHB en gestantes del HCVB fue de 0.3%, similar a la población general en Chile. No existió coinfección con otras enfermedades de transmisión sexual. El único factor predictor de infección por VHB fue la nacionalidad haitiana.

Abstract Bovine trypanosomosis, caused by Trypanosoma vivax, is a disease that originated in Africa and currently affects cattle in several South American countries, including almost all Brazilian states. Despite the reports on T. vivax infection in southern Brazil, data on its circulation status is currently unavailable. In this study, we aimed to detect anti-Trypanosoma spp. IgG antibodies in cattle from Rio Grande do Sul and suggest areas with T. vivax transmission risk. A total of 691 serum samples from cattle in the intermediate regions of Rio Grande do Sul were analyzed using indirect immunofluorescence assay (IFA). The overall seroprevalence of anti-Trypanosoma antibodies in cattle was 24.6% (170/691). The detection rate ranged from 0-37.3%, with a high prevalence in the intermediate regions of Ijuí (37.3%), Uruguaiana (30.7%), and Passo Fundo (28.9%). Thus, these regions were suggested as possible bovine trypanosomosis risk areas due to the high seroprevalence. This is the first serological study to determine Trypanosoma spp. infection status in cattle from Rio Grande do Sul, providing data on the epidemiology of trypanosomosis in the state. countries states T Brazil unavailable antiTrypanosoma anti spp 69 IFA. IFA . (IFA) 246 24 6 24.6 170/691. 170691 170/691 170 (170/691) 037.3%, 0373 0 37.3%, 37 3 0-37.3% 373 37.3% , (37.3%) 30.7%, 307 30.7% 30 7 (30.7%) 28.9%. 289 28.9% 28 9 (28.9%) Thus state (IFA 2 24. 17069 170/69 17 (170/691 037 037.3% 0-37.3 37.3 (37.3% 30.7 (30.7% 28.9 (28.9% 1706 170/6 1 (170/69 03 037.3 0-37. 37. (37.3 30. (30.7 28. (28.9 170/ (170/6 037. 0-37 (37. (30. (28. (170/ 0-3 (37 (30 (28 (170 0- (3 (2 (17 ( (1

Resumo A tripanossomose bovina, causada por Trypanosoma vivax, é uma doença que teve origem na África, e atualmente, afeta bovinos em diversos países da América do Sul, incluindo quase todos os estados brasileiros. Apesar dos relatos de infecção por T. vivax, no sul do Brasil, dados sobre seu status de circulação não estão disponíveis atualmente. Neste estudo, o objetivo foi detectar anticorpos IgG anti-Trypanosoma spp. em bovinos do Rio Grande do Sul e sugerir possíveis áreas de risco de transmissão de T. vivax. Foi analisado um total de 691 amostras de soro de bovinos, das regiões intermediárias do Rio Grande do Sul, usando-se o ensaio de imunofluorescência indireta (IFA). A soroprevalência geral de anticorpos anti-Trypanosoma em bovinos foi de 24,6% (170/691). A taxa de detecção variou de 0 a 37,3%, com uma alta prevalência nas regiões intermediárias de Ijuí (37,3%), Uruguaiana (30,7%) e Passo Fundo (28,9%). Portanto, essas regiões foram sugeridas como possíveis áreas de risco para a tripanossomose bovina, devido à alta soroprevalência. Este é o primeiro estudo sorológico a determinar o status de infecção por Trypanosoma spp., em bovinos do Rio Grande do Sul, fornecendo dados sobre a epidemiologia da tripanossomose no estado. bovina vivax África atualmente brasileiros T Brasil antiTrypanosoma anti spp 69 usandose usando se IFA. IFA . (IFA) 246 24 6 24,6 170/691. 170691 170/691 170 (170/691) 373 37 3 37,3% , (37,3%) 30,7% 307 30 7 (30,7% 28,9%. 289 28,9% 28 9 (28,9%) Portanto estado (IFA 2 24, 17069 170/69 17 (170/691 37,3 (37,3% 30,7 (30,7 28,9 (28,9% 1706 170/6 1 (170/69 37, (37,3 30, (30, 28, (28,9 170/ (170/6 (37, (30 (28, (170/ (37 (3 (28 (170 ( (2 (17 (1

Abstract Background While the sexual transmissibility of HAV in MSM has been extensively described, the potential for sexual transmission of HEV has not been definitively established. Although HEV has been detected in the ejaculate of chronically infected men, studies among MSM PrEP users in France did not observe an elevated anti-HEV seroprevalence as an indicator of increased exposure risk by sexual intercourse. Patients and methods A total of 111 unselected PrEP users and 111 age- and sex-matched blood donors were tested for anti-HEV IgG, IgM and HEV (PCR). Of the participants 79/111 (71 %) responded to a questionnaire covering topics as sexual preferences, previous sexually transmitted diseases, profession, food consumption, and pet ownership. Results The anti-HEV IgG seroprevalence in PrEP users (22 %) did not differ significantly from the rate in controls (17 %). While one PrEP user and three controls tested positive for anti-HEV IgM, all PrEP users and controls tested PCR negative. Conclusion In immunocompetent individuals with frequent changes of sexual partners, the epidemiology of Hepatitis E Virus does not significantly involve the sexual transmission route. described established men antiHEV anti intercourse 11 age sexmatched sex matched PCR. . (PCR) 79111 79 79/11 71 (7 % preferences diseases profession consumption ownership 22 (2 17 (1 %. negative partners route 1 (PCR 7911 7 79/1 ( 2 791 79/

ABSTRACT From February to December 2021, 960 serum samples from different climate regions in two Mexican states were analyzed for antibodies against EIAV using competitive enzyme-linked immunosorbent assay (cELISA) and agar gel immunodiffusion (AGID) tests. The overall seroprevalence of EIAV infection in equids determined by ELISA and AGID tests was 19.69% and 17.60%, respectively. The highest rate of seropositivity was observed in the state of Veracruz (23.67%, using AGID test), and the lowest rate was found in the state of Puebla (13.12%, using cELISA test). In total, 17.45% (85/487, using AGID test) and 15.40% (75/487, using cELISA test) of horses were positive for EIAV infection. Donkeys showed a prevalence of 19.87% (94/473) in cELISA and 21.99% (104/476) in AGID. The cELISA was compared with AGID as the gold standard test. The diagnostic sensitivity for horses and donkeys was 90.4% and 92.2%, and the specificity was 97.5% and 97.3%, respectively, with an almost perfect degree of agreement (kappa values of 0.871 and 0.888). Therefore, the overall seroprevalence rate of EIAV infection in equines in the sampled states of Puebla and Veracruz was 19.3%, with 91.4% sensitivity, 97.4% specificity, and an agreement of 96.25%, indicating almost perfect agreement (kappa = 0.880). 2021 96 enzymelinked enzyme linked (cELISA (AGID 1969 19 69 19.69 1760 17 60 17.60% respectively 23.67%, 2367 23 67 (23.67% test, test , 13.12%, 1312 13 12 (13.12% . total 1745 45 17.45 85/487, 85487 85 487 (85/487 1540 15 40 15.40 75/487, 75487 75 (75/487 1987 87 19.87 94/473 94473 94 473 (94/473 2199 21 99 21.99 104/476 104476 104 476 (104/476 904 90 4 90.4 922 92 2 92.2% 975 97 5 97.5 973 3 97.3% kappa 0871 0 871 0.87 0.888. 0888 0.888 888 0.888) Therefore 193 19.3% 914 91 91.4 974 97.4 9625 25 96.25% 0.880. 0880 0.880 880 0.880) 202 9 196 1 6 19.6 176 17.60 23.67% 236 (23.67 13.12% 131 (13.12 174 17.4 85/487 8548 8 48 (85/48 154 15.4 75/487 7548 7 (75/48 198 19.8 94/47 9447 47 (94/47 219 21.9 104/47 10447 10 (104/47 90. 92.2 97. 97.3 087 0.8 088 0.88 88 19.3 91. 962 96.25 20 19. 17.6 23.67 (23.6 13.12 (13.1 17. 85/48 854 (85/4 15. 75/48 754 (75/4 94/4 944 (94/4 21. 104/4 1044 (104/4 92. 08 0. 96.2 23.6 (23. 13.1 (13. 85/4 (85/ 75/4 (75/ 94/ (94/ 104/ (104/ 96. 23. (23 13. (13 85/ (85 75/ (75 (94 (104 (2 (1 (8 (7 (9 (10 (

RESUMO De fevereiro a dezembro de 2021, 960 amostras de soro de diferentes regiões climáticas em dois estados mexicanos foram analisadas quanto à presença de anticorpos contra o EIAV, por meio de testes de imunoabsorção enzimática competitiva (cELISA) e imunodifusão em gel de ágar (AGID). A soroprevalência geral da infecção por EIAV em equídeos, determinada pelos testes ELISA e AGID, foi de 19,69% (189 de 960 amostras de soro) e 17,60% (169 de 960 amostras de soro), respectivamente. A maior taxa de soropositividade foi observada no estado de Veracruz (23,67%, usando-se o teste AGID), e a menor taxa foi encontrada no estado de Puebla (13,12%, usando-se o teste cELISA). No total, 17,45% (85/487, usando-se o teste AGID) e 15,40% (75/487, usando-se o teste cELISA) dos cavalos foram positivos para a infecção por EIAV. Os jumentos apresentaram uma prevalência de 19,87% (94/473) no cELISA e 21,99% (104/476) no AGID. O cELISA foi comparado com o AGID como o teste padrão-ouro. A sensibilidade diagnóstica para cavalos e jumentos foi de 90,4% e 92,2%, e a especificidade foi de 97,5% e 97,3%, respectivamente, com um grau de concordância quase perfeito (valores kappa de 0,871 e 0,888). Portanto, a taxa de soroprevalência geral da infecção por EIAV em equinos nos estados de Puebla e Veracruz amostrados foi de 19,3%, com sensibilidade de 91,4%, especificidade de 97,4% e concordância de 96,25%, indicando concordância quase perfeita (kappa = 0,880). 2021 96 (cELISA . (AGID) equídeos 1969 19 69 19,69 189 (18 1760 17 60 17,60 169 (16 soro, , respectivamente 23,67%, 2367 23 67 (23,67% usandose usando se 13,12%, 1312 13 12 (13,12% cELISA. total 1745 45 17,45 85/487, 85487 85 487 (85/487 1540 15 40 15,40 75/487, 75487 75 (75/487 1987 87 19,87 94/473 94473 94 473 (94/473 2199 21 99 21,99 104/476 104476 104 476 (104/476 padrãoouro. padrãoouro padrão ouro. ouro padrão-ouro 904 90 4 90,4 922 92 2 92,2% 975 97 5 97,5 973 3 97,3% valores 0871 0 871 0,87 0,888. 0888 0,888 888 0,888) Portanto 193 19,3% 914 91 91,4% 974 97,4 9625 25 96,25% 0,880. 0880 0,880 880 0,880) 202 9 (AGID 196 1 6 19,6 18 (1 176 17,6 16 23,67% 236 (23,67 13,12% 131 (13,12 174 17,4 85/487 8548 8 48 (85/48 154 15,4 75/487 7548 7 (75/48 198 19,8 94/47 9447 47 (94/47 219 21,9 104/47 10447 10 (104/47 90, 92,2 97, 97,3 087 0,8 088 0,88 88 19,3 91,4 962 96,25 20 19, ( 17, 23,67 (23,6 13,12 (13,1 85/48 854 (85/4 15, 75/48 754 (75/4 94/4 944 (94/4 21, 104/4 1044 (104/4 92, 08 0, 91, 96,2 23,6 (23, 13,1 (13, 85/4 (85/ 75/4 (75/ 94/ (94/ 104/ (104/ 96, 23, (23 13, (13 85/ (85 75/ (75 (94 (104 (2 (8 (7 (9 (10

Abstract Background Patients with kidney disease on Hemodialysis (HD) are susceptible to Coronavirus Disease (COVID-19) due to multiple risk factors. Aim This study aims to report the prevalence of antibodies against SARS-CoV-2 among patients on hemodialysis before vaccination in Brazil and to compare with clinical, demographic, and laboratory data. Methods Blood samples from 398 Chronic Kidney Disease (CKD) patients treated in three different private institutions in Rio de Janeiro State, Brazil were submitted to the total anti-SARS-CoV-2 testing. Kidney, liver, and hematological markers were also determined. Respiratory samples were tested by real-time PCR for SARS-CoV-2 RNA and positive samples were subjected to high-throughput sequencing on the MinION device. Results Overall, anti-SARS-CoV-2 prevalence was 54.5 % (217/398) and two individuals had SARS-CoV-2 RNA with variant B.1.1. High anti-SARS-CoV-2 seroprevalence was found in male gender and those with hospital admission in the last 3-months before the inclusion in the study. Lower red blood cell count was observed in the anti-SARS-CoV-2 seropositive group. High levels of anti-SARS-CoV-2 were found in those who reported symptoms, had low levels of eosinophils and low hematocrit, and who practiced physical activity. Conclusion High prevalence of anti-SARS-CoV-2 was found in CKD patients before the universal immunization in Brazil suggesting that dialysis patients were highly exposed to SARS-CoV-2. HD (HD COVID19 COVID 19 (COVID-19 factors SARSCoV2 SARSCoV SARS CoV 2 SARS-CoV- clinical demographic data 39 (CKD State antiSARSCoV2 antiSARSCoV anti anti-SARS-CoV- testing liver determined realtime real time highthroughput high throughput device Overall 545 54 5 54. 217/398 217398 217 (217/398 B11 B 1 B.1.1 3months months 3 group symptoms hematocrit activity SARSCoV2. 2. COVID1 (COVID-1 SARS-CoV anti-SARS-CoV 217/39 21739 21 (217/39 B1 B.1. (COVID- 217/3 2173 (217/3 B.1 (COVID 217/ (217/ B. (217 (21 (2 (

Abstract: Since May 2020, we have been conducting a comprehensive study to understand the natural history of SARS-CoV-2 infection in Rio de Janeiro, Brazil. Our focus has been on following families, systematically collecting respiratory tract swabs and blood samples, monitoring symptoms, and gathering data on vaccine status. This paper aims to describe the household cohort across five epidemic waves of SARS-CoV-2, providing an overview of the collected data and a description of the epidemiological, clinical, and immunological characteristics and incidence of SARS-CoV-2 infection. Our cohort includes 691 participants from 189 households. During the five epidemic waves, we detected 606 infections. The incidence density of SARS-CoV-2 infection ranged from 4 (Delta) to 56 (B.1.1.33) per 1,000 person-week, with a peak in wave B.1.1.33 in all age groups. The seroprevalence of SARS-CoV-2 antibodies (IgG anti spike protein) varied from 37%, in the pre-VoC period, to 99%, in the Omicron period, progressively increasing after each wave in a similar manner regardless of age. As we have monitored the cohort continuously since the beginning of the pandemic, we were able to collect data across different scenarios according to the predominant lineage in circulation. Via active monitoring of families, we were able to carry out an epidemiological surveillance on SARS-CoV-2, including its variants, persistence of symptoms, and changes in immunity over time in the population, contributing to knowledge of the natural history of SARS-CoV-2 infection.

Resumen: Desde mayo de 2020 se realiza un estudio exhaustivo con el fin de estimar el curso natural de la infección por SARS-CoV-2 en Río de Janeiro, Brasil. Se aplica un seguimiento a las familias en el cual se recolectan sistemáticamente muestras de sangre y de las vías respiratorias, se controlan los síntomas y se recogen datos sobre el estado de vacunación. Este artículo tiene como objetivo describir la cohorte de hogares durante cinco olas epidémicas de SARS-CoV-2, y proporcionar una visión general de los datos recopilados y una descripción de las características epidemiológicas, clínicas e inmunológicas, y de la incidencia de la infección por SARS-CoV-2. La cohorte incluyó a 691 participantes de 189 hogares. A lo largo de las cinco olas epidémicas, se detectaron 606 infecciones. La densidad de incidencia de la infección por SARS-CoV-2 varió de 4 (Delta) a 56 (B.1.1.33) por cada 1.000 personas por semana, y fue más alta en la ola B.1.1.33 en todos los grupos de edad. La seroprevalencia de anticuerpos contra el SARS-CoV-2 (proteína IgG antipico) varió del 37% en el período anti-VOC al 99% en el período Ómicron y aumentó ola tras ola de manera similar, independientemente de la edad de los participantes. El monitoreo continuo de la cohorte desde el comienzo de la pandemia permitió recopilar datos en diferentes escenarios según la cepa predominante en circulación. A partir del monitoreo activo de las familias, se realizó una vigilancia epidemiológica del SARS-CoV-2, sus variantes, la persistencia de los síntomas y los cambios en la inmunidad de la población a lo largo del tiempo, contribuyendo al conocimiento del curso natural de la infección por SARS-CoV-2.

Resumo: Desde maio de 2020, temos conduzido um estudo abrangente para entender a história natural da infecção por SARS-CoV-2 no Rio de Janeiro, Brasil. Nosso foco tem sido acompanhar as famílias das quais coletamos sistematicamente amostras de sangue e do trato respiratório, monitoramos os sintomas e reunimos dados sobre o status de vacinação. Este artigo tem como objetivo descrever a coorte de domicílios ao longo de cinco ondas epidêmicas de SARS-CoV-2, fornecendo uma visão geral dos dados coletados e uma descrição das características epidemiológicas, clínicas e imunológicas e da incidência da infecção por SARS-CoV-2. Nossa coorte inclui 691 participantes de 189 domicílios. Ao longo das cinco ondas epidêmicas, detectamos 606 infecções. A densidade de incidência da infecção por SARS-CoV-2 variou de 4 (Delta) a 56 (B.1.1.33) a cada 1.000 pessoas por semana e foi mais alta na onda B.1.1.33 em todas as faixas etárias. A soroprevalência de anticorpos contra o SARS-CoV-2 (proteína IgG anti-spike) variou de 37% no período pré-VoC a 99% no período Omicron e aumentou onda após onda de maneira semelhante, independentemente da idade dos participantes. Como monitoramos a coorte continuamente desde o início da pandemia, pudemos coletar dados em diferentes cenários, de acordo com a cepa predominante em circulação. Por meio do monitoramento ativo das famílias, conseguimos conduzir uma vigilância epidemiológica do SARS-CoV-2, de suas variantes, da persistência dos sintomas e das mudanças na imunidade da população ao longo do tempo, contribuindo para o conhecimento da história natural da infecção pelo SARS-CoV-2.

Abstract: Since May 2020, we have been conducting a comprehensive study to understand the natural history of SARS-CoV-2 infection in Rio de Janeiro, Brazil. Our focus has been on following families, systematically collecting respiratory tract swabs and blood samples, monitoring symptoms, and gathering data on vaccine status. This paper aims to describe the household cohort across five epidemic waves of SARS-CoV-2, providing an overview of the collected data and a description of the epidemiological, clinical, and immunological characteristics and incidence of SARS-CoV-2 infection. Our cohort includes 691 participants from 189 households. During the five epidemic waves, we detected 606 infections. The incidence density of SARS-CoV-2 infection ranged from 4 (Delta) to 56 (B.1.1.33) per 1,000 person-week, with a peak in wave B.1.1.33 in all age groups. The seroprevalence of SARS-CoV-2 antibodies (IgG anti spike protein) varied from 37%, in the pre-VoC period, to 99%, in the Omicron period, progressively increasing after each wave in a similar manner regardless of age. As we have monitored the cohort continuously since the beginning of the pandemic, we were able to collect data across different scenarios according to the predominant lineage in circulation. Via active monitoring of families, we were able to carry out an epidemiological surveillance on SARS-CoV-2, including its variants, persistence of symptoms, and changes in immunity over time in the population, contributing to knowledge of the natural history of SARS-CoV-2 infection. Abstract 2020 SARSCoV2 SARSCoV SARS CoV 2 SARS-CoV- Janeiro Brazil families samples symptoms status SARSCoV2, 2, clinical 69 18 households 60 infections Delta (Delta 5 B1133 B 1 33 (B.1.1.33 1000 000 1,00 personweek, personweek person week, week person-week B.1.1.3 groups IgG protein 37 37% preVoC pre VoC period 99 99% pandemic circulation variants population 202 SARS-CoV 6 B113 3 (B.1.1.3 100 00 1,0 B.1.1. 9 20 B11 (B.1.1. 10 0 1, B.1.1 B1 (B.1.1 B.1. (B.1. B.1 (B.1 B. (B. (B

Resumo: Desde maio de 2020, temos conduzido um estudo abrangente para entender a história natural da infecção por SARS-CoV-2 no Rio de Janeiro, Brasil. Nosso foco tem sido acompanhar as famílias das quais coletamos sistematicamente amostras de sangue e do trato respiratório, monitoramos os sintomas e reunimos dados sobre o status de vacinação. Este artigo tem como objetivo descrever a coorte de domicílios ao longo de cinco ondas epidêmicas de SARS-CoV-2, fornecendo uma visão geral dos dados coletados e uma descrição das características epidemiológicas, clínicas e imunológicas e da incidência da infecção por SARS-CoV-2. Nossa coorte inclui 691 participantes de 189 domicílios. Ao longo das cinco ondas epidêmicas, detectamos 606 infecções. A densidade de incidência da infecção por SARS-CoV-2 variou de 4 (Delta) a 56 (B.1.1.33) a cada 1.000 pessoas por semana e foi mais alta na onda B.1.1.33 em todas as faixas etárias. A soroprevalência de anticorpos contra o SARS-CoV-2 (proteína IgG anti-spike) variou de 37% no período pré-VoC a 99% no período Omicron e aumentou onda após onda de maneira semelhante, independentemente da idade dos participantes. Como monitoramos a coorte continuamente desde o início da pandemia, pudemos coletar dados em diferentes cenários, de acordo com a cepa predominante em circulação. Por meio do monitoramento ativo das famílias, conseguimos conduzir uma vigilância epidemiológica do SARS-CoV-2, de suas variantes, da persistência dos sintomas e das mudanças na imunidade da população ao longo do tempo, contribuindo para o conhecimento da história natural da infecção pelo SARS-CoV-2. Resumo 2020 SARSCoV2 SARSCoV SARS CoV 2 SARS-CoV- Janeiro Brasil respiratório vacinação SARSCoV2, 2, epidemiológicas SARSCoV2. 2. 69 18 60 infecções Delta (Delta 5 B1133 B 1 33 (B.1.1.33 1000 000 1.00 B.1.1.3 etárias proteína antispike anti spike anti-spike 37 préVoC pré VoC 99 semelhante pandemia cenários circulação variantes tempo 202 SARS-CoV 6 B113 3 (B.1.1.3 100 00 1.0 B.1.1. 9 20 B11 (B.1.1. 10 0 1. B.1.1 B1 (B.1.1 B.1. (B.1. B.1 (B.1 B. (B. (B

Resumen: Desde mayo de 2020 se realiza un estudio exhaustivo con el fin de estimar el curso natural de la infección por SARS-CoV-2 en Río de Janeiro, Brasil. Se aplica un seguimiento a las familias en el cual se recolectan sistemáticamente muestras de sangre y de las vías respiratorias, se controlan los síntomas y se recogen datos sobre el estado de vacunación. Este artículo tiene como objetivo describir la cohorte de hogares durante cinco olas epidémicas de SARS-CoV-2, y proporcionar una visión general de los datos recopilados y una descripción de las características epidemiológicas, clínicas e inmunológicas, y de la incidencia de la infección por SARS-CoV-2. La cohorte incluyó a 691 participantes de 189 hogares. A lo largo de las cinco olas epidémicas, se detectaron 606 infecciones. La densidad de incidencia de la infección por SARS-CoV-2 varió de 4 (Delta) a 56 (B.1.1.33) por cada 1.000 personas por semana, y fue más alta en la ola B.1.1.33 en todos los grupos de edad. La seroprevalencia de anticuerpos contra el SARS-CoV-2 (proteína IgG antipico) varió del 37% en el período anti-VOC al 99% en el período Ómicron y aumentó ola tras ola de manera similar, independientemente de la edad de los participantes. El monitoreo continuo de la cohorte desde el comienzo de la pandemia permitió recopilar datos en diferentes escenarios según la cepa predominante en circulación. A partir del monitoreo activo de las familias, se realizó una vigilancia epidemiológica del SARS-CoV-2, sus variantes, la persistencia de los síntomas y los cambios en la inmunidad de la población a lo largo del tiempo, contribuyendo al conocimiento del curso natural de la infección por SARS-CoV-2. Resumen 202 SARSCoV2 SARSCoV SARS CoV 2 SARS-CoV- Janeiro Brasil respiratorias vacunación SARSCoV2, 2, epidemiológicas inmunológicas SARSCoV2. 2. 69 18 60 infecciones Delta (Delta 5 B1133 B 1 33 (B.1.1.33 1000 000 1.00 semana B.1.1.3 proteína antipico 37 antiVOC anti VOC 99 similar circulación variantes tiempo 20 SARS-CoV 6 B113 3 (B.1.1.3 100 00 1.0 B.1.1. 9 B11 (B.1.1. 10 0 1. B.1.1 B1 (B.1.1 B.1. (B.1. B.1 (B.1 B. (B. (B